Drug Patenting in India: Potentially Lucrative, but a Difficult Task
January 8, 2010
Foley Partner George Best and Associate Photon Rao authored an article titled “Drug Patenting in India: Potentially Lucrative, but a Difficult Task” in the January 8, 2010 issue of BNA’s Pharmaceutical Law & Industry Report.
Reproduced with permission from Pharmaceutical Law & Industry Report, 8 PLIR 46, 01/08/2010. Copyright 2010 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com
Related Insights
June 12, 2025
Foley Career Perspectives
Foley Pride Month Program: Being an Active Ally in Tough Situations
In honor of Pride Month, Foley & Lardner welcomed back PFLAG National for the fifth year in a row to help us continue to advance in our…
June 12, 2025
Tariff & International Trade Resource
What Every Multinational Company Should Know About … Combating Fraud in India
Fraud continues to pose significant challenges across industries worldwide. For multinational companies operating in India, the country offers enormous opportunity — but also presents distinct operational and regulatory risks that require executive-level attention and strategic oversight.
June 11, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…